β-1,3-Gal-T4 Polyclonal Antibody

货号：ES3748
价格：面议
点击：2871

产品介绍

抗体信息

应用	WB;ELISA
反应种属	Human;Rat;Mouse;
别称	B3GALT4; GALT4; Beta-1; 3-galactosyltransferase 4; Beta-1,3-GalTase 4; Beta3Gal-T4; Beta3GalT4; GalT4; b3Gal-T4; Gal-T2; Ganglioside galactosyltransferase; UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	336
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	449
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	285
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	423
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	285
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	385
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	147
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	229
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	160
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	375
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	455
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	292
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	298
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	462
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	511
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	309
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	162
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	493
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	366
Anti-Certolizumab Neutralizing Recombinant Antibody \|抗赛妥珠单抗中和重组抗体(靶标：赛妥珠单抗中和抗体)	175